"She's just wired a different way," Stanford told MedPage Today, noting part of the consideration for using new GLP-1 ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

However, a key difference between the two medications is that Saxenda requires a daily injection. Like Wegovy, Saxenda is approved for use in adults with a BMI of 30 or higher. The medication is also ...

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...

a class of drugs that are used to treat Type 2 diabetes but have gained attention for their effectiveness in aiding weight ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...